Letter: A better way to spend Ineos’ Oxford gift

  22 January 2021

After reading “Ratcliffe’s Ineos makes £100m Oxford donation to tackle antibiotic resistance” (Report, January 19), my first thought was if half as much money was invested in preventive practice in human primary care and animal welfare, antimicrobial resistance (AMR) would be substantially de-fuelled, giving Ineos, Oxford university and others a much longer runway to get next-generation cures developed, trialled, peer reviewed and commercialised.

 

Further reading: Financial Times
Author(s): Giovanna Forte
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed